BERKELEY, Calif. and VANCOUVER, British Columbia, March 07, 2018 –BriaCell Therapeutics Corp. (“BriaCell” or the ...
BERKELEY, Calif. and VANCOUVER, British Columbia, March 1, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, February 7, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, February 6, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
– Further Investigation on Mechanism of Action of its Lead Drug Candidate, Bria-IMT™, at AACR ...
BERKELEY, Calif. and VANCOUVER, British Columbia, January 31, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, January 3, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
BERKELEY, Calif. and VANCOUVER, British Columbia, January 2, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
Berkeley, CA and Vancouver, BC – December 21, 2017 – BriaCell Therapeutics Corp. (“BriaCell” or ...
BERKELEY, Calif. and VANCOUVER, British Columbia, Dec. 05, 2017 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...
Accessibility Tools